116 related articles for article (PubMed ID: 1297232)
1. Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma.
Gridelli C; Pepe R; Airoma G; Incoronato P; Rossi A; Palazzolo G; Bianco AR
Tumori; 1992 Dec; 78(6):380-2. PubMed ID: 1297232
[TBL] [Abstract][Full Text] [Related]
2. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
Kasseyet S; Astoul P; Boutin C
Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568
[TBL] [Abstract][Full Text] [Related]
3. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II study.
Pinto C; Marino A; Guaraldi M; Melotti B; Piana E; Martoni A; Pannuti F
Am J Clin Oncol; 2001 Apr; 24(2):143-7. PubMed ID: 11319288
[TBL] [Abstract][Full Text] [Related]
5. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
6. The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.
Andreopoulou E; Ross PJ; O'Brien ME; Ford HE; Priest K; Eisen T; Norton A; Ashley S; Smith IE
Ann Oncol; 2004 Sep; 15(9):1406-12. PubMed ID: 15319247
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
Shimizu E; Ogura T; Sone S; Nakayama T; Doi H; Takishita Y; Bando H; Kobayashi M; Kimura K; Sasaki H
Oncology; 1993; 50(1):5-9. PubMed ID: 8380634
[TBL] [Abstract][Full Text] [Related]
10. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.
Middleton GW; Smith IE; O'Brien ME; Norton A; Hickish T; Priest K; Spencer L; Ashley S
Ann Oncol; 1998 Mar; 9(3):269-73. PubMed ID: 9602260
[TBL] [Abstract][Full Text] [Related]
11. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Gridelli C; Perrone F; Palmeri S; D'Aprile M; Cognetti F; Rossi A; Gebbia V; Pepe R; Veltri E; Airoma G; Russo A; Incoronato P; Scinto AF; Palazzolo G; Natali M; Leonardi V; Gallo C; De Placido S; Bianco AR
Ann Oncol; 1996 Oct; 7(8):821-6. PubMed ID: 8922196
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin and raltitrexed in the treatment of inoperable malignant pleural mesothelioma: results of a pilot study.
Maisano R; Caristi N; Toscano G; Aragona M; Spadaro P; Amadio P; Mare M; Zavettieri M; La Torre F
Tumori; 2001; 87(6):391-3. PubMed ID: 11989592
[TBL] [Abstract][Full Text] [Related]
15. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients.
Hastürk S; Tastepe I; Unlü M; Cetin G; Baris YI
J Chemother; 1996 Apr; 8(2):159-64. PubMed ID: 8708749
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Tsavaris N; Mylonakis N; Karvounis N; Bacoyiannis C; Briasoulis E; Skarlos D; Pavlidis N; Stamatelos G; Kosmidis P
Lung Cancer; 1994 Sep; 11(3-4):299-303. PubMed ID: 7812707
[TBL] [Abstract][Full Text] [Related]
17. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
Muers MF; Stephens RJ; Fisher P; Darlison L; Higgs CM; Lowry E; Nicholson AG; O'Brien M; Peake M; Rudd R; Snee M; Steele J; Girling DJ; Nankivell M; Pugh C; Parmar MK;
Lancet; 2008 May; 371(9625):1685-94. PubMed ID: 18486741
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
[TBL] [Abstract][Full Text] [Related]
19. A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial.
O'Brien ME; Watkins D; Ryan C; Priest K; Corbishley C; Norton A; Ashley S; Rowell N; Sayer R
Ann Oncol; 2006 Feb; 17(2):270-5. PubMed ID: 16317014
[TBL] [Abstract][Full Text] [Related]
20. A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy.
Umsawasdi T; Dhingra HM; Charnsangavej C; Luna MA
Cancer; 1991 Jan; 67(1):48-54. PubMed ID: 1898706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
